{"id":"W3035200754","doi":"10.1136/annrheumdis-2020-eular.2027","title":"THU0395 EFFICACY OF IXEKIZUMAB ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND OBJECTIVE SIGNS OF INFLAMMATION, STRATIFIED BY BASELINE CRP/SACROILIAC JOINT MRI STATUS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"University of California, San Francisco; National Institute for Health and Care Research; University of Leeds; NordForsk; University of Alberta; Brigham and Women's Hospital","keywords":"Medicine; Sacroiliitis; Internal medicine; Ankylosing spondylitis; Ixekizumab; Axial spondyloarthritis; Population; Placebo; Rheumatology; Gastroenterology; Physical therapy; Secukinumab; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008743457,0.0003502339,0.001055237,0.000178902,0.000163202,0.0006714893,0.0003335798,0.0004868498,0.001581631],"category_scores_gemma":[0.0009748033,0.0001627027,0.001152284,0.0002394228,0.0002602346,0.0003586874,0.0002098291,0.0009448679,0.0002125847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003710588,"about_ca_system_score_gemma":0.000409366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001058961,"about_ca_topic_score_gemma":0.001889753,"domain_scores_codex":[0.9996597,0.0001128415,0.00003300358,0.00005346048,0.0000415895,0.00009943995],"domain_scores_gemma":[0.9994461,0.0001967875,0.0001377319,0.00003783959,0.00002968486,0.0001518501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.52268,0.005938098,0.282725,0.0009807706,0.007562238,0.0005568843,0.0002877197,0.003199825,0.01316316,0.0004215165,0.002874774,0.1596099],"study_design_scores_gemma":[0.04780957,0.08800674,0.8515405,0.0001821155,0.00307735,0.0008213888,0.0002557304,0.003927632,0.002053349,0.0003151696,0.001939005,0.00007145452],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959912,0.002854602,0.00003394608,0.0001171697,0.0000499044,0.00001292451,0.000262045,0.000008861674,0.0006694507],"genre_scores_gemma":[0.9989556,0.0003313898,0.0000419249,0.0000765011,0.00003342155,0.00001002704,0.0002915529,0.000001008182,0.0002585066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001581631,"threshold_uncertainty_score":0.005291104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02638739636500727,"score_gpt":0.2722075740856552,"score_spread":0.2458201777206479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}